
    
      Purpose:

      Phase I:

      To Evaluate the safety of different doses of zosuquidar.

      Phase II:

      This study is designed to study the safety and effectiveness of zosuquidar when given with
      daunorubicin and cytarabine in newly diagnosed AML patients.
    
  